Join the club for FREE to access the whole archive and other member benefits.

Sergio Ruiz

Chief Operating Officer at Turn Biotechnologies.

As Managing Director of the Methuselah Fund, Sergio Ruiz has several years of experience discovering, analyzing, vetting and propelling longevity biotechnologies that can move the needle in the mission to increase the healthy human healthspan. He is also an entrepreneur-investor with a positive hands-on approach to investing who prides himself in helping with the incubation and formation of young academic teams and developing them into successful industry leaders. He currently holds several senior advisory roles for longevity biotechs and is also the Chief Operating Officer for a Stanford-born company called Turn Biotechnologies, focusing on epigenetic resetting of the age in a cell.

Visit website:



See also: Company Turn Biotechnologies - Focused on restoring cells’ youthful vigor to repair damage caused by the aging process

Sergio Ruiz is also referenced in the following:

Longevity Summit Dublin 2022

18-Sep-2022 to 20-Sep-2022

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Sergio Ruiz News

Longevity funding innovation prize: shaping the future of longevity research

Live Forever Club - 01-Nov-2023

A $20,000 prize for innovative approaches to increase longevity sector funding

Read more... summarises the proceedings of the Buck Institute's Longevity Summit (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials